-
公开(公告)号:US20230149345A1
公开(公告)日:2023-05-18
申请号:US17917022
申请日:2021-04-05
Applicant: The General Hospital Corporation
Inventor: David R. Elmaleh , Ana Griciuc , Ghazaleh Sadri-Vakili , Sabrina Paganoni , Rudolph E. Tanzi
IPC: A61K31/353 , A61P29/00 , A61P31/14 , A61P11/00 , A61K45/06
CPC classification number: A61K31/353 , A61P29/00 , A61P31/14 , A61P11/00 , A61K45/06
Abstract: The present disclosure relates to a method of treating one or more inflammation conditions induced by a coronavirus infection in a subject in need thereof, comprising administering a pharmaceutical composition comprising a compound of Formula I or Formula II, wherein R1 is halogen, OH, or —OC(O)C1-5alkyl, R2 and R3 are each independently selected from CO2R4 and CH2OR5; R4 is Li, Na, K, H, C1-5-alkyl, or —CH2CO(C1-5alkyl); and R5 is H or —C(O)(C1-5alkyl), or a pharmaceutically acceptable salt thereof.
-
公开(公告)号:US20220218652A1
公开(公告)日:2022-07-14
申请号:US17273646
申请日:2019-09-05
Applicant: The General Hospital Corporation , AZTherapies, Inc.
Inventor: David R. Elmaleh , Rudolph E. Tanzi , Ana Griciuc , Robert Warren , Karen Reeves
IPC: A61K31/352 , A61P37/06 , A61K45/06 , A61K38/17
Abstract: The present disclosure relates to a method of treating at least one Cell-Associated Neurotoxicity Syndrome (ICANS), cancer-related cognitive impairment, Infusion Reaction Syndrome (IRS), Capillary Leak Syndrome (CLS), Tumor Lysis Syndrome (TLS), Macrophage Activation Syndrome (MAS), Systemic Inflammatory Response Syndrome (SIRS), Immune Reconstitution Inflammatory Syndrome (IRIS), Graft-Versus-Host Disease (GVHD), Acute Respiratory Distress Syndrome (ARDS), sepsis, Ebola, avian influenza, smallpox, Systemic Inflammatory Response Syndrome (SIRS), and Immune-related Adverse Events Syndrome (IrAES) in a subject in need thereof, comprising administering a mast cell stabilizer or a compound of Formula I or Formula II: Formula I, Formula II, wherein R1 is halogen, OH, or —OC(O)C1-5alkyl R2 and R3 are each independently selected from CO2R4 or CH2OR5; R4 is i L, Na, K, H, C1-5alkyl, or —CH2CO(C1-5alkyl); and R5 is H or C(O)(C1-5alkyl), or a pharmaceutically acceptable salt thereof.
-
公开(公告)号:US11117884B2
公开(公告)日:2021-09-14
申请号:US16664621
申请日:2019-10-25
Inventor: Steven L. Wagner , William C. Mobley , Rudolph E. Tanzi , Graham Johnson , Ronald Buckle , Nicholas Mayhew , Robert Jason Herr , Kevin D. Rynearson
IPC: C07D401/14 , C07D413/14 , C07D487/04 , A61P25/28
Abstract: Provided herein are compounds and methods for treating a disorder associated with aberrant Aβ peptide levels, including Alzheimer's disease.
-
4.
公开(公告)号:US20140377267A1
公开(公告)日:2014-12-25
申请号:US14453007
申请日:2014-08-06
Inventor: Robert Moir , Rudolph E. Tanzi
IPC: C07K16/18
CPC classification number: C07K16/18 , A61K2039/505 , C07K2317/21 , C07K2317/24 , C07K2317/54 , G01N33/6896 , G01N2333/4709 , G01N2800/2821
Abstract: The invention relates to antibodies that bind cross-linked amyloid β oligomers, and methods for using such antibodies for diagnosis and treatment of Alzheimer's disease.
Abstract translation: 本发明涉及结合交联淀粉样蛋白的抗体; 低聚物和使用这种抗体来诊断和治疗阿尔茨海默病的方法。
-
公开(公告)号:US20200055840A1
公开(公告)日:2020-02-20
申请号:US16664621
申请日:2019-10-25
Inventor: Steven L. Wagner , William C. Mobley , Rudolph E. Tanzi , Graham Johnson , Ronald Buckle , Nicholas Mayhew , Robert Jason Herr , Kevin D. Rynearson
IPC: C07D401/14 , A61P25/28 , C07D487/04 , C07D413/14
Abstract: Provided herein are compounds and methods for treating a disorder associated with aberrant Aβ peptide levels, including Alzheimer's disease.
-
公开(公告)号:US20240148832A1
公开(公告)日:2024-05-09
申请号:US18274677
申请日:2022-02-04
Applicant: The General Hospital Corporation
Inventor: Cameron McAlpine , Filip K. Swirski , Rudolph E. Tanzi
CPC classification number: A61K38/202 , A61K9/0019 , A61P25/28
Abstract: Described herein are compositions and methods targeting IL-3 signaling for reducing Alzheimer's disease (AD)-related pathology.
-
公开(公告)号:US20220079914A1
公开(公告)日:2022-03-17
申请号:US17323514
申请日:2021-05-18
Applicant: The General Hospital Corporation
Inventor: David R. Elmaleh , Rudolph E. Tanzi , Timothy M. Shoup , Ana Griciuc
IPC: A61K31/352 , C07D311/24 , C07D311/22 , A61P25/28 , A61K9/00
Abstract: Described herein are methods of treating neuron inflammation conditions, for example, Alzheimer's disease, Parkinson's disease, Huntington's disease, ischemic stroke, and prion disease, comprising administering a therapeutically effective amount of cromolyn or a cromolyn derivative compound.
-
8.
公开(公告)号:US20190240194A1
公开(公告)日:2019-08-08
申请号:US16328956
申请日:2017-08-31
Applicant: The General Hospital Corporation
Inventor: David R. Elmaleh , Rudolph E. Tanzi , Timothy M. Shoup , Ana Gricluc
IPC: A61K31/352 , A61P25/28 , A61K9/00
CPC classification number: A61K31/352 , A61K9/0019 , A61K9/0073 , A61K45/06 , A61P25/28 , C07D311/22 , C07D311/24
Abstract: Described herein are methods of treating neuron inflammation conditions, for example, Alzheimer's disease, Parkinson's disease, Huntington's disease, ischemic stroke, and prion disease, comprising administering a therapeutically effective amount of cromolyn or a cromolyn derivative compound.
-
公开(公告)号:US20240174608A1
公开(公告)日:2024-05-30
申请号:US18279162
申请日:2022-03-11
Applicant: The General Hospital Corporation
Inventor: Changning Wang , Yulong Xu , Can Zhang , Rudolph E. Tanzi
IPC: C07D209/88 , A61K51/04 , C07B59/00
CPC classification number: C07D209/88 , A61K51/0446 , C07B59/002 , A61K2123/00 , C07B2200/05
Abstract: The present application provides radiolabeled tetrahydrocarbazole compounds that can be used as positron emission tomography imaging probes. Pharmaceutical compositions and methods of using these compounds for diagnosis and monitoring treatment of neurodegenerative diseases (such as Alzheimer's disease) are also provided.
-
10.
公开(公告)号:US20240082207A1
公开(公告)日:2024-03-14
申请号:US18210992
申请日:2023-06-16
Applicant: The General Hospital Corporation
Inventor: David R. Elmaleh , Rudolph E. Tanzi , Timothy M. Shoup , Ana Gircluc
IPC: A61K31/352 , A61K9/00 , A61P25/28 , C07D311/22 , C07D311/24
CPC classification number: A61K31/352 , A61K9/0019 , A61K9/0073 , A61P25/28 , C07D311/22 , C07D311/24 , A61K45/06
Abstract: Described herein are methods of treating neuron inflammation conditions, for example, Alzheimer's disease, Parkinson's disease, Huntington's disease, ischemic stroke, and prion disease, comprising administering a therapeutically effective amount of cromolyn or a cromolyn derivative compound.
-
-
-
-
-
-
-
-
-